海王生物(000078.SZ):擬以1.85億元受讓珠海華夏基金所持部分項目股權及債權
格隆匯4月11日丨海王生物(000078.SZ)公佈,公司於2022年1月28日召開的第八屆董事局第二十五次會議審議通過了《關於解散並清算產業投資合夥企業的議案》,同意解散並清算珠海華夏基金。
珠海華夏基金自成立以來一直圍繞醫藥行業投資標的進行投資並對其進行培育,現經公司謹慎選擇,擬篩選與公司主營業務形成良好協同效應的投資標的放入公司體系,同時為進一步推進珠海華夏基金的清算工作,公司擬收購部分公司的債權。
公司此次擬以人民幣合計1.85億元受讓珠海華夏基金所持有的部分項目股權及債權:公司擬以人民幣6300萬元受讓珠海華夏基金所持有的上海聚力康10.92%股權,以人民幣5200萬元受讓江蘇德威蘭259.07萬股股份(對應江蘇德威蘭持股比例7.43%)及1000萬元相關債權,以人民幣6000萬元受讓南京科藴璽6163.32萬元債權,以人民幣1000萬元受讓呼倫貝爾海康1132.81萬元債權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.